
CHME China Medicine CorporationStock Price & Overview
Stock Price & Overview
$0.0001
CHME Stock Price
Quant Ranking
CHME Analysis










Latest Headlines
People Also Follow
Similar to CHME
ETFs Holding CHME
CHME Company Profile
China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The company offers various products for applications, including oncology, high blood pressure, and removal of toxins from food and animal feeds. It provides products that treat stagnation of the heart blood, obstruction of qi in the chest, cardiodynia, headache, and dysmenorrhea; upper respiratory tract infection, acute faucitis, acute tonsillitis, acute gastroenteritis, etc.; acute and chronic hepatitis, deferment hepatitis, cholecystitis, etc.; irregular menstruation, dysmenorrhea, and amenorrhea; anemia and deficiency of vital energy; palpitation, dizziness, and fatigue; and cerebral arteriosclerosis and ischemic stroke. The company distributes its products through a sales network in China. The company was formerly known as Lounsberry Holdings III, Inc. and changed its name to China Medicine Corporation in May 2006. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China.
CHME Revenue
CHME Earnings Per Share
Earnings Revisions
Profitability
Momentum
Dividends
CHME Ownership
CHME Peers
Risk
Technicals
CHME SEC Filings
CHME Income Statement
CHME Balance Sheet
Discover More
You may be interested in: